Yoon; Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yoon; Paul.The latest application filed is for "x-ray psoralen activated cancer therapy (x-pact)".

Company Profile

4.5.8

Yoon; Paul - Durham NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
X-ray Psoralen Activated Cancer Therapy (x-pact) App 20220226666 - Oldham; Mark ; et al.	2022-07-21
X-ray psoralen activated cancer therapy (X-PACT) Grant 11,305,131 - Oldham , et al. April 19, 2	2022-04-19
Methods For Radiotherapy To Trigger Light Activation Drugs App 20220062419 - OLDHAM; Mark ; et al.	2022-03-03
X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments Grant 11,207,409 - Bourke, Jr. , et al. December 28, 2	2021-12-28
Methods for radiotherapy to trigger light activation drugs Grant 11,135,294 - Oldham , et al. October 5, 2	2021-10-05
Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use Grant 10,940,329 - Oldham , et al. March 9, 2	2021-03-09
X-ray Psoralen Activated Cancer Therapy (x-pact) App 20200009398 - OLDHAM; Mark ; et al.	2020-01-09
X-ray psoralen activated cancer therapy (X-PACT) Grant 10,441,810 - Oldham , et al. Oc	2019-10-15
Phosphor-containing Drug Activator Activatable By A Monte Carlo Derived X-ray Exposure, System Containing The Activator, And Met App 20190184190 - WALDER; Harold ; et al.	2019-06-20
X-ray Psoralen Activated Cancer Therapy (x-pact) With Associated Treatments App 20180344850 - BOURKE, JR.; Frederic A. ; et al.	2018-12-06
Methods For Radiotherapy To Trigger Light Activation Drugs App 20180311355 - OLDHAM; Mark ; et al.	2018-11-01
Phosphor-containing Drug Activator Activatable By A Monte Carlo Derived X-ray Exposure, System Containing The Activator, And Methods For Use App 20180154178 - Oldham; Mark ; et al.	2018-06-07
X-ray Psoralen Activated Cancer Therapy (x-pact) App 20170157418 - OLDHAM; Mark ; et al.	2017-06-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.